A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blinded, randomised, placebo-controlled trial

Facial angiofibromas (FA) are a major feature of tuberous sclerosis complex (TSC).Topical rapamycin can successfully treat FA. A new stabilised cream formulation which protects rapamycin from oxidation has been developed in 0.5% and 1% concentrations. To assess the efficacy and safety of a novel sta...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of dermatology (1951) 2023-07
Hauptverfasser:	Aitken, Phillip, Stanescu, Ioana, Boddington, Laura, Mahon, Caroline, Fogarasi, Andras, Liao, Yi-Hua, Ivars, Marta, Moreno-Artero, Ester, Trauner, Doris, DeRoos, Steven T, Jancic, Jasna, Nikolic, Milos, Balážová, Patrícia, Price, Harper N, Hadzsiev, Kinga, Riney, Kate, Stapleton, Stacie, Tollefson, Megha M, Bauer, Derek, Pinková, Blanka, Atkinson, Hartley
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!